Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis

Authors: Serge Lavoie, Isabelle Côté, André Pichette, Charles Gauthier, Michaël Ouellet, Francine Nagau-Lavoie, Vakhtang Mshvildadze, Jean Legault

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Many plants of boreal forest of Quebec have been used by Native Americans to treat a variety of microbial infections. However, the antiviral activities of these plants have been seldom evaluated on cellular models to validate their in vitro efficiencies. In this study, Cornus canadensis L. (Cornaceae), a plant used in Native American traditional medicine to treat possible antiviral infections, has been selected for further examination.

Methods

The plant was extracted by decoction and infusion with water, water/ethanol 1:1 and ethanol to obtain extracts similar to those used by Native Americans. The effects of the extracts were tested on herpes simplex virus type-1 (HSV-1) using a plaque reduction assay. Moreover, bioassay-guided fractionation was achieved to isolate bioactive compounds.

Results

Water/ethanol 1:1 infusion of C. canadensis leaves were the most active extracts to inhibit virus absorption with EC50 of about 9 μg mL−1, whereas for direct mode, both extraction methods using water or water/ethanol 1:1 as solvent were relatively similar with EC50 ranging from 11 to 17 μg mL−1. The fractionation led to the identification of active fractions containing hydrolysable tannins. Tellimagrandin I was found the most active compound with an EC50 of 2.6 μM for the direct mode and 5.0 μM for the absorption mode.

Conclusion

Altogether, the results presented in this work support the antiviral activity of Cornus canadensis used in Native American traditional medicine.
Literature
1.
go back to reference Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Gottlieb SL, Newman LM. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10. Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Gottlieb SL, Newman LM. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10.
2.
go back to reference Stock C, Guillén-Grima F, De Mendoza JH, Marin-Fernandez B, Aguinaga-Ontoso I, Krämer A. Risk factors of herpes simplex type 1 (HSV-1) infection and lifestyle factors associated with HSV-1 manifestations. Eur J Epidemiol. 2001;17:885–90.CrossRefPubMed Stock C, Guillén-Grima F, De Mendoza JH, Marin-Fernandez B, Aguinaga-Ontoso I, Krämer A. Risk factors of herpes simplex type 1 (HSV-1) infection and lifestyle factors associated with HSV-1 manifestations. Eur J Epidemiol. 2001;17:885–90.CrossRefPubMed
3.
go back to reference Whitley RJ, Tyring SK, Hollier LM, Brunton SA. Emerging issues in the management of herpes simplex virus infections. Johns Hopkins Advanced Studies in Medicine. 2006;6:S1092–103. Whitley RJ, Tyring SK, Hollier LM, Brunton SA. Emerging issues in the management of herpes simplex virus infections. Johns Hopkins Advanced Studies in Medicine. 2006;6:S1092–103.
4.
go back to reference Dreno B, Malkin JE, Saiag P. Understanding recurrent herpes labialis management and impact on patients’ quality of life: The HERPESCOPE study. Eur J Dermatol. 2013;23:491–9.PubMed Dreno B, Malkin JE, Saiag P. Understanding recurrent herpes labialis management and impact on patients’ quality of life: The HERPESCOPE study. Eur J Dermatol. 2013;23:491–9.PubMed
6.
go back to reference Steiner I, Benninger F. Update on herpes virus infections of the nervous system. Curr Neurol Neurosci Rep. 2013;13:414.CrossRefPubMed Steiner I, Benninger F. Update on herpes virus infections of the nervous system. Curr Neurol Neurosci Rep. 2013;13:414.CrossRefPubMed
7.
go back to reference James SH, Prichard MN. Current and future therapies for herpes simplex virus infections: Mechanism of action and drug resistance. Curr Opin Virol. 2014;8:54–61.CrossRefPubMed James SH, Prichard MN. Current and future therapies for herpes simplex virus infections: Mechanism of action and drug resistance. Curr Opin Virol. 2014;8:54–61.CrossRefPubMed
8.
go back to reference Cunningham A, Griffiths P, Leone P, Mindel A, Patel R, Stanberry L, Whitley R. Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol. 2012;53:6–11.CrossRefPubMed Cunningham A, Griffiths P, Leone P, Mindel A, Patel R, Stanberry L, Whitley R. Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol. 2012;53:6–11.CrossRefPubMed
9.
go back to reference Orion E, Matz H, Wolf R. The life-threatening complications of dermatologic therapies. Clin Dermatol. 2005;23:182–92.CrossRefPubMed Orion E, Matz H, Wolf R. The life-threatening complications of dermatologic therapies. Clin Dermatol. 2005;23:182–92.CrossRefPubMed
10.
go back to reference Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79:629–61.CrossRefPubMed Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79:629–61.CrossRefPubMed
11.
go back to reference Hassan STS, Masarčíková R, Berchová K. Bioactive natural products with anti-herpes simplex virus properties. J Pharm Pharmacol. 2015;67:1325–36.CrossRefPubMed Hassan STS, Masarčíková R, Berchová K. Bioactive natural products with anti-herpes simplex virus properties. J Pharm Pharmacol. 2015;67:1325–36.CrossRefPubMed
13.
go back to reference Moerman DE. Native american ethnobotany. Portland: Timber Press Inc.; 1998. Moerman DE. Native american ethnobotany. Portland: Timber Press Inc.; 1998.
14.
go back to reference Wagner H, Bladt S. Plant Drug Analysis. A Thin Layer Chromatography Atlas. 2nd ed. Berlin Heidelberg New York: Springer-Verlag; 1996. Wagner H, Bladt S. Plant Drug Analysis. A Thin Layer Chromatography Atlas. 2nd ed. Berlin Heidelberg New York: Springer-Verlag; 1996.
15.
go back to reference Owen RW, Haubner R, Hull WE, Erben G, Spiegelhalder B, Bartsch H, Haber B. Isolation and structure elucidation of the major individual polyphenols in carob fibre. Food Chem Toxicol. 2003;41:1727–38.CrossRefPubMed Owen RW, Haubner R, Hull WE, Erben G, Spiegelhalder B, Bartsch H, Haber B. Isolation and structure elucidation of the major individual polyphenols in carob fibre. Food Chem Toxicol. 2003;41:1727–38.CrossRefPubMed
16.
go back to reference Wang KJ, Yang CR, Zhang YJ. Phenolic antioxidants from Chinese toon (fresh young leaves and shoots of Toona sinensis). Food Chem. 2006;101:365–71.CrossRef Wang KJ, Yang CR, Zhang YJ. Phenolic antioxidants from Chinese toon (fresh young leaves and shoots of Toona sinensis). Food Chem. 2006;101:365–71.CrossRef
17.
go back to reference Cheng KW, Yang RY, Tsou SCS, Lo CSC, Ho CT, Lee TC, Wang M. Analysis of antioxidant activity and antioxidant constituents of Chinese toon. J Funct Foods. 2009;1:253–9.CrossRef Cheng KW, Yang RY, Tsou SCS, Lo CSC, Ho CT, Lee TC, Wang M. Analysis of antioxidant activity and antioxidant constituents of Chinese toon. J Funct Foods. 2009;1:253–9.CrossRef
18.
go back to reference Cho JY, Sohn MJ, Lee J, Kim WG. Isolation and identification of pentagalloylglucose with broad-spectrum antibacterial activity from Rhus trichocarpa Miquel. Food Chem. 2010;123:501–6.CrossRef Cho JY, Sohn MJ, Lee J, Kim WG. Isolation and identification of pentagalloylglucose with broad-spectrum antibacterial activity from Rhus trichocarpa Miquel. Food Chem. 2010;123:501–6.CrossRef
19.
go back to reference Chen Y, Wang J, Ou Y, Chen H, Xiao S, Liu G, Cao Y, Huang Q. Cellular antioxidant activities of polyphenols isolated from Eucalyptus leaves (Eucalyptus grandis × Eucalyptus urophylla GL9). J Funct Foods. 2014;7:737–45.CrossRef Chen Y, Wang J, Ou Y, Chen H, Xiao S, Liu G, Cao Y, Huang Q. Cellular antioxidant activities of polyphenols isolated from Eucalyptus leaves (Eucalyptus grandis × Eucalyptus urophylla GL9). J Funct Foods. 2014;7:737–45.CrossRef
20.
go back to reference Takaoka S, Takaoka N, Minoshima Y, Huang JM, Kubo M, Harada K, Hioki H, Fukuyama Y. Isolation, synthesis, and neurite outgrowth-promoting activity of illicinin A from the flowers of Illicium anisatum. Tetrahedron. 2009;65:8354–61.CrossRef Takaoka S, Takaoka N, Minoshima Y, Huang JM, Kubo M, Harada K, Hioki H, Fukuyama Y. Isolation, synthesis, and neurite outgrowth-promoting activity of illicinin A from the flowers of Illicium anisatum. Tetrahedron. 2009;65:8354–61.CrossRef
21.
go back to reference Kelley CJ, Harruff RC, Carmack M. Polyphenolic acids of Lithospermum ruderale. II. Carbon-13 nuclear magnetic resonance of lithospermic and rosmarinic acids. J Org Chem. 1976;41:449–55.CrossRef Kelley CJ, Harruff RC, Carmack M. Polyphenolic acids of Lithospermum ruderale. II. Carbon-13 nuclear magnetic resonance of lithospermic and rosmarinic acids. J Org Chem. 1976;41:449–55.CrossRef
22.
go back to reference Han JT, Bang MH, Chun OK, Kim DO, Lee CY, Baek NI. Flavonol glycosides from the aerial parts of Aceriphyllum rossii and their antioxidant activities. Arch Pharmacal Res. 2004;27:390–5.CrossRef Han JT, Bang MH, Chun OK, Kim DO, Lee CY, Baek NI. Flavonol glycosides from the aerial parts of Aceriphyllum rossii and their antioxidant activities. Arch Pharmacal Res. 2004;27:390–5.CrossRef
23.
go back to reference Scharbert S, Holzmann N, Hofmann T. Identification of the astringent taste compounds in black tea infusions by combining instrumental analysis and human bioresponse. J Agric Food Chem. 2004;52:3498–508.CrossRefPubMed Scharbert S, Holzmann N, Hofmann T. Identification of the astringent taste compounds in black tea infusions by combining instrumental analysis and human bioresponse. J Agric Food Chem. 2004;52:3498–508.CrossRefPubMed
24.
go back to reference Hyun AJ, Ae RK, Hae YC, Jae SC. In vitro antioxidant activity of some selected Prunus species in Korea. Arch Pharmacal Res. 2002;25:865–72.CrossRef Hyun AJ, Ae RK, Hae YC, Jae SC. In vitro antioxidant activity of some selected Prunus species in Korea. Arch Pharmacal Res. 2002;25:865–72.CrossRef
25.
go back to reference Kadota S, Takamori Y, Khin NN, Kikuchi T, Tanaka K. Ekimoto. Constituents of the leaves of Woodfordia fruticosa KURZ. I. Isolation, structure, and proton and carbon-13 nuclear magnetic resonance signal assignments of woodfruticosin (Woodfordin C), an inhibitor of deoxyribonucleic acid topoisomerase II. Chem Pharm Bull. 1990;38:2687–97.CrossRefPubMed Kadota S, Takamori Y, Khin NN, Kikuchi T, Tanaka K. Ekimoto. Constituents of the leaves of Woodfordia fruticosa KURZ. I. Isolation, structure, and proton and carbon-13 nuclear magnetic resonance signal assignments of woodfruticosin (Woodfordin C), an inhibitor of deoxyribonucleic acid topoisomerase II. Chem Pharm Bull. 1990;38:2687–97.CrossRefPubMed
26.
go back to reference Hyoung KJ, Woo E-R, Park H. A novel lignan and flavonoids from Polygonum aviculare. J Nat Prod. 1994;57:581–6.CrossRef Hyoung KJ, Woo E-R, Park H. A novel lignan and flavonoids from Polygonum aviculare. J Nat Prod. 1994;57:581–6.CrossRef
27.
go back to reference Lin HC, Tsai SF, Lee SS. Flavonoid glycosides from the leaves of Machilus philippinensis. J Chin Chem Soc. 2011;58:555–62.CrossRef Lin HC, Tsai SF, Lee SS. Flavonoid glycosides from the leaves of Machilus philippinensis. J Chin Chem Soc. 2011;58:555–62.CrossRef
28.
go back to reference D’Abrosca B, DellaGreca M, Fiorentino A, Monaco P, Previtera L, Simonet AM, Zarrelli A. Potential allelochemicals from Sambucus nigra. Phytochemistry. 2001;58:1073–81.CrossRefPubMed D’Abrosca B, DellaGreca M, Fiorentino A, Monaco P, Previtera L, Simonet AM, Zarrelli A. Potential allelochemicals from Sambucus nigra. Phytochemistry. 2001;58:1073–81.CrossRefPubMed
29.
go back to reference Matsunami K, Otsuka H, Takeda Y. Structural revisions of blumenol C glucoside and byzantionoside B. Chem Pharm Bull. 2010;58:438–41.CrossRefPubMed Matsunami K, Otsuka H, Takeda Y. Structural revisions of blumenol C glucoside and byzantionoside B. Chem Pharm Bull. 2010;58:438–41.CrossRefPubMed
30.
31.
go back to reference O’Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem. 2000;267:5421–6.CrossRefPubMed O’Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem. 2000;267:5421–6.CrossRefPubMed
32.
go back to reference Koch C, Reichling J, Schneele J, Schnitzler P. Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine. 2008;15:71–8.CrossRefPubMed Koch C, Reichling J, Schneele J, Schnitzler P. Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine. 2008;15:71–8.CrossRefPubMed
33.
go back to reference Stermitz FR, Krull RE. Iridoid glycosides of Cornus canadensis: A comparison with some other Cornus species. Biochem Syst Ecol. 1998;26:845–9.CrossRef Stermitz FR, Krull RE. Iridoid glycosides of Cornus canadensis: A comparison with some other Cornus species. Biochem Syst Ecol. 1998;26:845–9.CrossRef
34.
go back to reference Bermejo P, Abad MJ, Díaz AM, Fernández L, De Santos J, Sanchez S, Villaescusa L, Carrasco L, Irurzun A. Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from Bupleurum rigidum and Scrophularia scorodonia. Planta Med. 2002;68:106–10.CrossRefPubMed Bermejo P, Abad MJ, Díaz AM, Fernández L, De Santos J, Sanchez S, Villaescusa L, Carrasco L, Irurzun A. Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from Bupleurum rigidum and Scrophularia scorodonia. Planta Med. 2002;68:106–10.CrossRefPubMed
35.
go back to reference Bain JF, Denford KE. The flavonoid glycosides of Cornus canadensis L. and its allies in Northwestern North America. Experientia. 1979;35:863–4.CrossRef Bain JF, Denford KE. The flavonoid glycosides of Cornus canadensis L. and its allies in Northwestern North America. Experientia. 1979;35:863–4.CrossRef
36.
go back to reference Khan MTH, Ather A, Thompson KD, Gambari R. Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res. 2005;67:107–19.CrossRefPubMed Khan MTH, Ather A, Thompson KD, Gambari R. Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res. 2005;67:107–19.CrossRefPubMed
37.
go back to reference Kaul TN, Middleton Jr E, Ogra PL. Antiviral effect of flavonoids on human viruses. J Med Virol. 1985;15:71–9.CrossRefPubMed Kaul TN, Middleton Jr E, Ogra PL. Antiviral effect of flavonoids on human viruses. J Med Virol. 1985;15:71–9.CrossRefPubMed
38.
go back to reference Takechi M, Tanaka Y, Takehara M, Nonaka GI, Nishioka I. Structure and antiherpetic activity among the Tannins. Phytochemistry. 1985;24:2245–50.CrossRef Takechi M, Tanaka Y, Takehara M, Nonaka GI, Nishioka I. Structure and antiherpetic activity among the Tannins. Phytochemistry. 1985;24:2245–50.CrossRef
39.
go back to reference Kurokawa M, Hozumi T, Basnet P, Nakano M, Kadota S, Namba T, Kawana T, Shiraki K. Purification and characterization of Eugeniin as an anti-herpes virus compound from Geum japonicum and Syzygium aromaticum. J Pharmacol Exp Ther. 1998;284:728–35.PubMed Kurokawa M, Hozumi T, Basnet P, Nakano M, Kadota S, Namba T, Kawana T, Shiraki K. Purification and characterization of Eugeniin as an anti-herpes virus compound from Geum japonicum and Syzygium aromaticum. J Pharmacol Exp Ther. 1998;284:728–35.PubMed
40.
go back to reference Pei Y, Chen ZP, Ju HQ, Komatsu M, Ji YH, Liu G, Guo CW, Zhang YJ, Yang CR, Wang YF, Kitazato K. Autophagy is involved in anti-viral activity of pentagalloylglucose (PGG) against Herpes simplex virus type 1 infection in vitro. Biochem Biophys Res Commun. 2011;405:186–91.CrossRefPubMed Pei Y, Chen ZP, Ju HQ, Komatsu M, Ji YH, Liu G, Guo CW, Zhang YJ, Yang CR, Wang YF, Kitazato K. Autophagy is involved in anti-viral activity of pentagalloylglucose (PGG) against Herpes simplex virus type 1 infection in vitro. Biochem Biophys Res Commun. 2011;405:186–91.CrossRefPubMed
41.
go back to reference Pei Y, Xiang YF, Chen JN, Lu CH, Hao J, Du Q, Lai CC, Qu C, Li S, Ju HQ, Ren Z, Liu QY, Xiong S, Qian CW, Zeng FL, Zhang PZ, Yang CR, Zhang YJ, Xu J, Kitazato K, Wang YF. Pentagalloylglucose downregulates cofilin1 and inhibits HSV-1 infection. Antiviral Res. 2011;89:98–108.CrossRefPubMed Pei Y, Xiang YF, Chen JN, Lu CH, Hao J, Du Q, Lai CC, Qu C, Li S, Ju HQ, Ren Z, Liu QY, Xiong S, Qian CW, Zeng FL, Zhang PZ, Yang CR, Zhang YJ, Xu J, Kitazato K, Wang YF. Pentagalloylglucose downregulates cofilin1 and inhibits HSV-1 infection. Antiviral Res. 2011;89:98–108.CrossRefPubMed
42.
go back to reference Fukuchi K, Sakagami H, Okuda T, Hatano T, Tanuma S, Kitajima K, Inoue Y, Inoue S, Ichikawa S, Nonoyama M, Konno K. Inhibition of herpes simplex virus infection by tannins and related compounds. Antiviral Res. 1989;11:285–97.CrossRefPubMed Fukuchi K, Sakagami H, Okuda T, Hatano T, Tanuma S, Kitajima K, Inoue Y, Inoue S, Ichikawa S, Nonoyama M, Konno K. Inhibition of herpes simplex virus infection by tannins and related compounds. Antiviral Res. 1989;11:285–97.CrossRefPubMed
43.
go back to reference Legault J, Pichette A, Côté I, Lavoie S, inventors. Université du Québec à Chicoutimi, assignee. Use of plant extracts against herpes simplex virus. World patent WO 2015/010205 A1. 2015 January 29 Legault J, Pichette A, Côté I, Lavoie S, inventors. Université du Québec à Chicoutimi, assignee. Use of plant extracts against herpes simplex virus. World patent WO 2015/010205 A1. 2015 January 29
Metadata
Title
Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis
Authors
Serge Lavoie
Isabelle Côté
André Pichette
Charles Gauthier
Michaël Ouellet
Francine Nagau-Lavoie
Vakhtang Mshvildadze
Jean Legault
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1618-2

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue